Dr. Bold is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
13400 E Shea Blvd
Scottsdale, AZ 85259Phone+1 480-301-8000
Education & Training
- Brandeis UniversityMBA, 2019 - 2020
- University of Texas M D Anderson Cancer CenterFellowship, Complex General Surgical Oncology, 1996 - 1998
- University of California Davis HealthInternship, Transitional Year, 1989 - 1990
- Stanford University School of MedicineClass of 1989
- University of California, San DiegoBA, Biochemistry, 1981 - 1985
Certifications & Licensure
- CA State Medical License 1991 - 2026
- AZ State Medical License 2023 - 2025
- TX State Medical License 1996 - 1998
- American Board of Surgery Surgery
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2012
- Fellow (FACS) American College of Surgeons
Publications & Presentations
PubMed
- 39 citationsUnplanned Hospitalization Among Individuals With Cancer in the Year After Diagnosis.Robin L. Whitney, Janice F. Bell, Daniel J. Tancredi, Patrick S Romano, Richard J. Bold
Journal of Oncology Practice. 2019-01-01 - 88 citationsRORγ is a targetable master regulator of cholesterol biosynthesis in a cancer subtype.Demin Cai, Junjian Wang, Bei Gao, Jin Li, Feng Wu
Nature Communications. 2019-10-11 - 17 citations"Development of the proteasome inhibitor Velcade (Bortezomib)" by Julian Adams, Ph.D., and Michael Kauffman, M.D., Ph.D.Richard J. Bold
Cancer Investigation. 2004-01-01
Press Mentions
- Cancer Center’s Physician-in-Chief Leads PurpleStrideApril 12th, 2023
- UC Davis Health Sponsors Biggest Breast Cancer Fundraiser in NorCalSeptember 22nd, 2021
- Get Outdoors but Stay Skin Safe with Free UC Davis Health Sunscreen StationsAugust 12th, 2021
- Join now to see all
Grant Support
- Targeting AKT As A Novel Therapy In Pancreatic CancerNational Cancer Institute2006–2007
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: